Status:
UNKNOWN
Sequential Oxygen Therapy Strategy for Patients With COVID-19
Lead Sponsor:
Henan Provincial People's Hospital
Conditions:
Coronavirus Disease-2019
Eligibility:
All Genders
18-75 years
Brief Summary
All patients with COVID-19 were divided into three groups according to their illness: mild patient who receive conventional oxygen therapy, severe patients who receive nasal high flow oxygen inhalatio...
Eligibility Criteria
Inclusion
- Patients diagnosed with COVID-19
- Aged between 18-75 years;
- Willing to sign the informed consent voluntarily.
Exclusion
- Patients with active tuberculosis, idiopathic pulmonary fibrosis, bronchial asthma, bronchiectasis, pulmonary embolism, chronic respiratory failure or other serious respiratory diseases; ② patients with serious cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina, acute myocardial infarction, cardiac function grade 3 or above, stroke, cerebral hemorrhage, etc.); ③ Patients with serious hepatorenal diseases (serious liver diseases refer to cirrhosis, portal hypertension and varicose bleeding, and serious kidney diseases include dialysis and kidney transplantation); ④ tumor patients who have undergone resection, radiotherapy and chemotherapy within 5 years; ⑤ patients who have difficulty in activity due to neuromuscular diseases; ⑥ patients with serious arthritis; ⑦ patients with serious peripheral vascular diseases; ⑧ Pregnant and lactating women; ⑨ with severe cognitive and mental disorders; ⑩ the clinical researchers who were participating in other interventions within one month before selection;
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04312100
Start Date
February 1 2020
End Date
February 1 2021
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan Provincial People's Hospital
Zhengzhou, Henan, China, 450000